Ignite Creation Date:
2024-05-05 @ 11:36 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00093080
Status:
COMPLETED
Last Update Posted:
2015-02-13
First Post:
2004-09-30
Brief Title:
Study of AP23573MK-8669 Ridaforolimus A Mammalian Target of Rapamycin mTOR Inhibitor in Participants With Advanced Sarcoma MK-8669-018 AM1COMPLETED
Sponsor:
Organization:
Merck Sharp Dohme LLC